New treatment option for Mental Health Care
Official title Feasibility and Acceptability of Group Medical Visits for Anxiety and Depression
ClinicalTrials.gov ID: NCT06651801
What this study is testing
- What it's testing
- The goal of this clinical trial is to evaluate the feasibility and acceptability of the intervention, Group Medical Visits (GMVs), for patients with depression and anxiety. It also aims to get some initial information on the effectiveness of GMVs on reducing depression and anxiety scores, which will help inform power calculations for a future larger randomized controlled trial (RCT).
- Which group you join is decided by chance.
A plain-language read of the study's public ClinicalTrials.gov listing. The study team confirms the details.
Who can take part
Ages 18 and older
You may be able to join if
- Adult Central Intake patients (patients referred for psychiatric consultation by their primary care provider) whose primary mental health issue is an...
- Able to participate in English language group with up to 10 participants
- Able to commit to a virtual biweekly group for about 1.5 hours each group
- Able to do virtual group from a private location with camera access
- Live in community in Manitoba and plan to stay for 6-month period
You likely can't join if
- Patients with Bipolar 1 or 2 Disorder (even if current episode depression)
- Primary diagnosis of a personality disorder leading to anxiety/depression symptoms (personality disorder traits are not an exclusion criteria)
- Patients who already have established longitudinal care with a psychiatrist
- Received ECT treatment within past 6 months
- Any diagnosis that would significantly impact ability to participate in the group. For example:
- Moderate-to-severe substance use disorders (in particular substance use throughout day or inability to attend group without using substances before)
See the full eligibility criteria
- Adult Central Intake patients (patients referred for psychiatric consultation by their primary care provider) whose primary mental health issue is an anxiety disorder (social anxiety, generalized anxiety, or panic...
- Able to participate in English language group with up to 10 participants
- Able to commit to a virtual biweekly group for about 1.5 hours each group
- Able to do virtual group from a private location with camera access
- Live in community in Manitoba and plan to stay for 6-month period
- Patients with Bipolar 1 or 2 Disorder (even if current episode depression)
- Primary diagnosis of a personality disorder leading to anxiety/depression symptoms (personality disorder traits are not an exclusion criteria)
- Patients who already have established longitudinal care with a psychiatrist
- Received ECT treatment within past 6 months
- Any diagnosis that would significantly impact ability to participate in the group. For example:
- Moderate-to-severe substance use disorders (in particular substance use throughout day or inability to attend group without using substances before)
- Current psychotic symptoms
- Moderate-to-severe intellectual disability or neurocognitive disorder
- Current significant eating disorder symptoms (for example resulting in significant weight loss/malnutrition or that take up a significant part of the day either mentally or physically)
- Self harm behaviour requiring medical/psychiatric attention or active suicidal ideation/suicide attempts within the past 6 months
- Concern about safety of other group members/facilitators if this patient were to join
The study team makes the final eligibility decision.
Where it's taking place
- Winnipeg, Manitoba, Canada
Questions & answers
Do participants get paid in this trial?
This listing doesn't specify compensation. Many trials still reimburse travel or offer a stipend, so it's worth asking the study team when you connect.
Is it free to join, and do I need insurance?
Searching and applying through BridgeMD is free. In clinical trials the study-related treatment and visits are generally provided at no cost to you. You usually don't need insurance to take part - confirm specifics with the study team.
How long does this study last?
The listing doesn't state an exact length. The study team walks you through the schedule and number of visits before you decide to enroll.
Who can join this trial?
This study is enrolling all sexes, 18 years and older. The study team makes the final eligibility decision.
Where is this trial taking place?
Study sites include Winnipeg, Manitoba, Canada. Enter your location above to see the nearest site and check your eligibility.
Explore other conditions
BridgeMD is an information and trial-matching tool - not medical advice, and not the study sponsor. Details come from ClinicalTrials.gov; the study team decides eligibility.